NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting
February 25, 2020 13:58 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Feb. 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the American Academy of Pain Medicine (AAPM) 36th...
NeuroMetrix Reports Q4 and Full Year 2019 Financial Results
January 27, 2020 07:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 27, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2019. The Company...
NeuroMetrix, Inc. 2019 Financial Conference Call Rescheduled to Monday January 27, 2020
January 22, 2020 10:43 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced the shift of its 2019 financial conference call to Monday, January 27, 2020 at 8:00am Eastern Time....
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2019 Financial Results Conference Call
January 17, 2020 12:49 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 17, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 fourth quarter and full year financial results before the opening of...
NeuroMetrix Announces One-for-Ten Reverse Split
November 18, 2019 11:50 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock. The shares underlying the...
NeuroMetrix Reports Q3 2019 Financial Results
October 17, 2019 07:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019. The Company develops and...
NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy
October 15, 2019 11:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets,...
NeuroMetrix, Inc. Announces Date for Third Quarter 2019 Financial Results Conference Call
October 10, 2019 11:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on...
NeuroMetrix Reports Q2 2019 Financial Results
July 18, 2019 07:00 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call
July 11, 2019 13:15 ET
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on...